Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
Addressing the challenge of diabetic macular edema with ILUVIEN®: views from the Expert User Group Meeting in Rome, November 17, 2018
Could nitisinone increase melanin production in patients with albinism?
The image shows en face OCT visualization of macular photoreceptor loss in choroideremia
Sitting Down With… Paulo Stanga, Consultant Ophthalmologist and Vitreoretinal Surgeon, Manchester Royal Eye Hospital
Gene therapies are no longer just hype – they provide tangible benefits to real patients, today
Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery
Our newfound ability to harness the power of gene therapy is facing an age-old challenge: financial constraints
Reflecting on the past – and future – of gene therapy
Plasmid vectors are gaining traction as a viable alternative in gene therapy delivery
A quest to tackle LCA emphasizes the essence of precision medicine
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.